Using the industry peer median P/E Multiples multiple (trailing + forward), Village Farms International, Inc. (VFF) has a fair value of $4.67 based on 1 comparable companies in the Agricultural Farm Products industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing P/E | Forward P/E | |
|---|---|---|---|
| Village Farms International, Inc.VFF | 318 | 9.8x | 14.6x |
| USANA Health Sciences, Inc. | 323 | 30.2x | 6.1x |
| Industry Median | 30.2x | 6.1x | |
| (*) Profit after tax | 32 | 22 | |
| Equity Value | 980 | 146 | |
| (/) Outstanding shares | 121 | 121 | |
| Fair Price | $8 | $1 | |
Using the industry peer median EV/EBITDA multiple (trailing + forward), Village Farms International, Inc. (VFF) has a fair value of $3.72 based on 3 comparable companies in the Agricultural Farm Products industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/EBITDA | Forward EV/EBITDA | |
|---|---|---|---|
| Village Farms International, Inc.VFF | 318 | 5.5x | 4.9x |
| B&G Foods, Inc. | 403 | 24.2x | 22.9x |
| USANA Health Sciences, Inc. | 323 | 2.0x | 2.1x |
| CHS Inc. | 312 | 2.2x | — |
| Industry Median | 2.2x | 12.5x | |
| (*) EBITDA | 50 | 56 | |
| = Enterprise Value | 112 | 700 | |
| (-) Net Debt | -42 | -42 | |
| Equity Value | 155 | 743 | |
| (/) Outstanding shares | 121 | 121 | |
| Fair Price | $1 | $6 | |
Using the industry peer median EV/Revenue multiple (trailing + forward), Village Farms International, Inc. (VFF) has a fair value of $2.97 based on 5 comparable companies in the Agricultural Farm Products industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| Village Farms International, Inc.VFF | 318 | 1.3x | 1.1x |
| B&G Foods, Inc. | 403 | 1.3x | 1.2x |
| Alico, Inc. | 330 | 8.6x | 53.5x |
| USANA Health Sciences, Inc. | 323 | 0.2x | 0.2x |
| CHS Inc. | 312 | 0.1x | — |
| Limoneira Company | 237 | 1.9x | 1.7x |
| Industry Median | 1.3x | 1.5x | |
| (*) Revenue | 216 | 240 | |
| = Enterprise Value | 277 | 355 | |
| (-) Net Debt | -42 | -42 | |
| Equity Value | 320 | 397 | |
| (/) Outstanding shares | 121 | 121 | |
| Fair Price | $3 | $3 | |
Using the PEG framework with analyst consensus forward EPS growth of 8.0%, the company has a fair value of $1.44 based on NTM EPS (FY2026) of $0.18. The current PEG ratio is 2.79.
PEG < 1 = bargain, 1–1.5 = fair, > 2 = expensive.
PEG tends to undervalue slow growers — consider dividend yield and asset value instead.
| EPS Growth RateForward | 5.4% |
| Adjusted Growth (clamped 8–25%)Clamped | 8.0% |
| Fair P/E | 8.0x |
| NTM EPS (FY2026) | $0.18 |
| Fair Value | $1.44 |
| Period | EPS Est. | Growth | Analysts |
|---|---|---|---|
| FY2025 (actual) | $0.27 | — | — |
| FY2026E | $0.18 | -33.3% | 3 |
| FY2027E | $0.30 | +66.7% | 3 |
2Y Forward EPS CAGR: 5.4%
| Year | Net Income | EPS | YoY |
|---|---|---|---|
| FY2021 | $-9.1M | $-0.11 | — |
| FY2022 | $-101.1M | $-1.11 | — |
| FY2023 | $-34.8M | $-0.29 | — |
| FY2024 | $-35.9M | $-0.32 | — |
| FY2025 | $32.4M | $0.27 | — |
4Y Historical EPS CAGR: 0.0%
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.